TNFα release is strongly suppressed by steroids, while IL-1β poorly responds to this class of anti-inflammatory drugs and its high levels are associated with steroid-resistant neutrophilic inflammation typical of COPD patients. Here, IL1B is linked to chronic obstructive pulmonary disease.